Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.375 GBX | -2.17% | -.--% | -3.57% |
Apr. 17 | ReNeuron Group Reports CFO Resignation | MT |
Apr. 17 | ReNeuron CFO steps down to pursue other opportunities | AN |
Sales 2022 | 403K 504K | Sales 2023 | 530K 662K | Capitalization | 5.17M 6.46M |
---|---|---|---|---|---|
Net income 2022 | -9M -11.25M | Net income 2023 | -5M -6.25M | EV / Sales 2022 | 8.48 x |
Net cash position 2022 | 13.99M 17.47M | Net cash position 2023 | 6.73M 8.41M | EV / Sales 2023 | -2.94 x |
P/E ratio 2022 |
-1.79
x | P/E ratio 2023 |
-0.96
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 78.26% |
Latest transcript on ReNeuron Group plc
1 day | -2.17% | ||
6 months | -36.92% | ||
Current year | -3.57% |
Managers | Title | Age | Since |
---|---|---|---|
Suzanne Hancock
COO | Chief Operating Officer | - | 16-12-31 |
Chief Tech/Sci/R&D Officer | - | 22-03-02 | |
Simon Dew
PRN | Corporate Officer/Principal | - | 22-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Martin Walton
BRD | Director/Board Member | 61 | 22-03-21 |
Iain Ross
CHM | Chairman | 71 | 21-06-30 |
Director/Board Member | 61 | 21-07-13 |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-3.57% | 2.43M | |
+21.74% | 46.81B | |
-0.97% | 41.37B | |
+47.07% | 41.29B | |
-3.52% | 28.87B | |
+11.12% | 26.06B | |
-19.37% | 19.13B | |
+31.18% | 12.39B | |
-0.04% | 12.08B | |
+0.39% | 11.96B |
- Stock Market
- Equities
- RENE Stock